Utang jangka cendhak marang modal Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical - logo grafis emiten ISRG

The launch of the Da Vinci 5 system is driving procedural growth, which is reflected in the history of short-term debt-to-equity ratios for Intuitive Surgical (ISRG). However, ISRG expansion is being hindered by export controls and geopolitics, while the high cost of equipment amid rising competition is pressuring margins. The value of 0.00 expresses the metric level, demonstrating the balance between leverage and protecting capital from dilution.

ISRG: Koefisien utang jangka cendhak marang modal Intuitive Surgical, Inc. 04.07.2022 - 28.10.2026
Produk merek Intuitive

For Intuitive Surgical (ISRG), the launch of the Da Vinci 5 system sees the ratio of short-term liabilities to equity reflect a balance between current liquidity and development resources. This metric compares short-term credit obligations against the net value of shareholders' equity. An increase in this ratio signals potential cash shortage risks, while a minimum indicates conservative management. Low leverage confirms the financial stability of Intuitive Surgical (ISRG) during its expansion into Asian markets.

Analisis perusahaan pesaing

Danaher Corp - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Becton Dickinson & Company (BDX)|STE - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal westpharma.com WST|Utang jangka cendhak marang modal BAX (Baxter)|MASI - Koefisien utang jangka cendhak marang modal|STVN (Stevanato) - Utang jangka cendhak marang modal|Teleflex Corp (TFX) - Rasio utang jangka cendhak marang ekuitas|MMSI (Merit Medical Systems) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal NVST|Utang jangka cendhak marang ekuitas ICU Medical (ICUI)|Utang jangka cendhak marang ekuitas Dentsply Sirona Inc XRAY|Rasio utang jangka cendhak marang ekuitas LeMaitre|Rasio tanggungan utang jangka cendhak marang modal AtriCure Medical ATRC|Utang jangka cendhak marang modal STAA (STAAR Surgical Company)|NAGE: Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas ZimVie|ANGO (AngioDynamics Inc) - Rasio utang jangka cendhak marang modal|CERS: Utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Teknova Inc (TKNO)|Rasio utang jangka cendhak marang ekuitas Monogram Technologies|Rasio silihan jangka cendhak marang modal STSS (sharpstechnology.com)|Utang jangka cendhak marang ekuitas InfuSystem Holdings, Inc.|UTMD - Rasio tanggungan utang jangka cendhak marang modal|KORU Medical Systems Inc. - Rasio utang jangka cendhak marang ekuitas|NYXH: Utang jangka cendhak marang modal|MBOT (Microbot Medical Inc.) - Utang jangka cendhak marang ekuitas|pro-dex.com (PDEX) - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal ZTEK (Zentek)|Kewajiban jangka cendhak marang modal ELUT|Utang jangka cendhak marang ekuitas Milestone Scientific Corp MLSS|Rasio utang jangka cendhak marang modal NEXGEL Inc NXGL|Rasio utang jangka cendhak marang ekuitas Retractable Technologies, Inc. (RVP)|Harvard Bioscience Inc. - Rasio silihan jangka cendhak marang modal|Utang jangka cendhak marang ekuitas FEMY (Femasys)|MHUA - Koefisien utang jangka cendhak marang modal|predictive-oncology.com - Utang jangka cendhak marang modal|CJMB (Callan JMB) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Atrion Corporation (ATRI)|Rasio utang jangka cendhak marang modal neurometrix.com (NURO)